Promomed received a GMP certificate for the UAE market

Promomed Group's Biochemist plant has successfully passed an audit by the UAE Medicines Authority and has confirmed its compliance with international GMP requirements. Company is now able to supply pharmaceutical products to one of the most promising markets in the Middle East. UAE's pharmaceutical market reached $4.7 billion in 2024. It is expected to exceed $7 billion by 2030.